Illinois Municipal Retirement Fund raised its holdings in Henry Schein, Inc. (NASDAQ:HSIC – Free Report) by 6.5% during the first quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 112,671 shares of the company’s stock after purchasing an additional 6,835 shares during the quarter. Illinois Municipal Retirement Fund’s holdings in Henry Schein were worth $8,304,000 as of its most recent SEC filing.
Several other hedge funds and other institutional investors also recently modified their holdings of the business. Invesco Ltd. lifted its position in shares of Henry Schein by 4.1% during the 3rd quarter. Invesco Ltd. now owns 4,731,698 shares of the company’s stock worth $314,043,000 after buying an additional 184,763 shares during the last quarter. Dimensional Fund Advisors LP grew its position in Henry Schein by 8.5% in the fourth quarter. Dimensional Fund Advisors LP now owns 2,816,317 shares of the company’s stock valued at $212,865,000 after acquiring an additional 220,149 shares during the last quarter. Ameriprise Financial Inc. grew its position in Henry Schein by 11.3% in the third quarter. Ameriprise Financial Inc. now owns 2,523,014 shares of the company’s stock valued at $167,453,000 after acquiring an additional 256,156 shares during the last quarter. Southpoint Capital Advisors LP raised its stake in Henry Schein by 38.9% during the fourth quarter. Southpoint Capital Advisors LP now owns 2,500,000 shares of the company’s stock worth $188,950,000 after acquiring an additional 700,000 shares in the last quarter. Finally, Bank of Montreal Can lifted its holdings in shares of Henry Schein by 3,655.7% in the fourth quarter. Bank of Montreal Can now owns 2,144,773 shares of the company’s stock worth $162,102,000 after acquiring an additional 2,087,666 shares during the last quarter. Institutional investors own 96.62% of the company’s stock.
Insider Buying and Selling
In other news, Director William K. Daniel purchased 10,000 shares of the business’s stock in a transaction on Monday, May 11th. The shares were acquired at an average price of $69.19 per share, with a total value of $691,900.00. Following the completion of the transaction, the director owned 20,000 shares of the company’s stock, valued at $1,383,800. The trade was a 100.00% increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Company insiders own 0.89% of the company’s stock.
Henry Schein Stock Down 0.5%
Henry Schein (NASDAQ:HSIC – Get Free Report) last posted its quarterly earnings data on Tuesday, May 5th. The company reported $1.32 earnings per share for the quarter, topping the consensus estimate of $1.20 by $0.12. Henry Schein had a net margin of 2.95% and a return on equity of 15.44%. The company had revenue of $3.37 billion during the quarter, compared to analysts’ expectations of $3.34 billion. During the same period in the prior year, the company posted $1.15 earnings per share. Henry Schein’s revenue for the quarter was up 6.3% compared to the same quarter last year. Henry Schein has set its FY 2026 guidance at 5.230-5.370 EPS. Equities analysts forecast that Henry Schein, Inc. will post 5.32 earnings per share for the current year.
Wall Street Analysts Forecast Growth
A number of equities analysts recently issued reports on HSIC shares. Citigroup started coverage on shares of Henry Schein in a research report on Wednesday, April 15th. They set a “buy” rating and a $100.00 price objective for the company. Mizuho decreased their target price on shares of Henry Schein from $88.00 to $82.00 and set a “neutral” rating on the stock in a research note on Wednesday, May 6th. Wall Street Zen downgraded shares of Henry Schein from a “buy” rating to a “hold” rating in a report on Sunday, July 12th. Robert W. Baird set a $97.00 price target on Henry Schein in a research note on Wednesday, May 6th. Finally, BMO Capital Markets began coverage on Henry Schein in a report on Wednesday, July 8th. They set a “market perform” rating and a $85.00 price objective on the stock. Seven analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, Henry Schein currently has a consensus rating of “Hold” and a consensus price target of $87.64.
Get Our Latest Research Report on HSIC
Henry Schein Profile
Henry Schein, Inc is a leading global distributor of healthcare products and services, primarily serving office-based dental, medical and animal health practitioners. The company operates through three principal segments—Schein Dental, Schein Medical and Animal Health—each offering a comprehensive portfolio of consumable products, equipment, instruments and related value-added services. With a focus on improving practice efficiency and patient care, Henry Schein provides everything from dental restorative materials and orthodontic appliances to vaccines, pharmaceuticals and diagnostic devices for physicians, as well as pet health products and veterinary equipment for animal health professionals.
In addition to its broad product offering, Henry Schein delivers a suite of technology and service solutions aimed at streamlining workflows and enhancing clinical outcomes.
Featured Articles
- Five stocks we like better than Henry Schein
- AST SpaceMobile Stock Sinks as SpaceX Fallout Rattles Space Sector
- Aehr Test Systems Stock Soars on Earnings, Eyes Over 150% Revenue Growth
- TSMC Just Gave AI Chip Bulls Another Reason to Stay Confident
- GE Aerospace Faces a Prove-It Moment in Q2 Earnings
Want to see what other hedge funds are holding HSIC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Henry Schein, Inc. (NASDAQ:HSIC – Free Report).
Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.
